GHK-Cu Copper Peptide: Mechanism of Action, Skin Regeneration & Collagen Research

For laboratory and research use only. Not for human consumption.

Loren Pickart didn’t set out to discover one of the most studied peptides in regenerative research. It was 1973, he was looking at liver tissue, and he stumbled onto a copper-bound tripeptide hiding in human plasma. That accident — if you want to call it that — launched fifty years of research across wound healing, collagen biology, gene expression, and a half-dozen other fields that weren’t even on anyone’s radar at the time.

The peptide was GHK-Cu (glycyl-L-histidyl-L-lysine copper complex). It’s tiny — three amino acids and a copper ion. And somehow it touches over 4,000 human genes. This article breaks down what researchers actually know about it so far, what the data looks like, and why it keeps showing up in new studies.

What Is GHK-Cu Peptide?

Your body already makes this stuff. GHK-Cu isn’t lab-designed — it’s a copper(II) complex of the peptide glycyl-L-histidyl-L-lysine, and it shows up in blood, saliva, and urine. The wrinkle (no pun intended) is that levels crash as we get older. When you’re 20, plasma concentration sits near 200 ng/mL. Fast forward to 60 and it’s fallen to about 80 ng/mL. Sixty percent gone. That timeline mirrors the decline in skin elasticity, wound closure speed, and overall tissue repair capacity that aging brings. Coincidence? Researchers don’t think so, and the gene expression data backs them up.

Property	Value
Peptide Sequence	Glycyl-L-Histidyl-L-Lysine
Abbreviation	GHK-Cu
CAS Number	49557-75-7
Molecular Formula (GHK)	C14H24N6O4
Molecular Weight (free peptide)	340.38 g/mol
Molecular Weight (GHK-Cu complex)	~401.93 g/mol
Metal Ion	Copper(II) / Cu2+
Source	Naturally occurring in human plasma
Classification	Copper-binding tripeptide

How GHK-Cu Was Discovered

Pickart wasn’t even looking for a peptide — that’s the irony. He had old liver tissue and young liver tissue, and wanted to know why they made proteins so differently. So he took a fraction of human serum albumin, applied it to the aged cells, and watched. The old cells started acting young again. Different protein synthesis patterns. As if decades of aging had been rolled back in a dish.

Four more years of work and by 1977 he’d isolated the active component. A tripeptide. Glycine, histidine, lysine — bound to copper. Pickart would spend the next 46 years expanding on that discovery (he died in 2023). A liver study turned into wound healing research, then skin, then inflammation, then gene expression. Every time someone looked at a new system, GHK-Cu was doing something interesting there too.

GHK-Cu Chemistry and Structure

Glycine, histidine, lysine. That’s it — the whole peptide. Three amino acids in a line. You could sketch it on a napkin. What makes it interesting isn’t the peptide itself; it’s what happens when copper enters the picture.

The Cu(II) ion grabs hold through three nitrogen atoms. One from histidine’s imidazole ring. One from glycine’s alpha-amino group. One from the deprotonated amide bond between the first two residues. The resulting binding constant sits around log K = 16.44 at physiological pH, which is biochemistry’s way of saying “good luck pulling that apart.”

Why care about the copper? Because it runs essential machinery. Lysyl oxidase won’t cross-link your collagen without it. Superoxide dismutase — a front-line antioxidant enzyme — shuts down. Cytochrome c oxidase stops, and with it goes mitochondrial energy production. Copper isn’t optional in biology. It’s infrastructure. And GHK-Cu is one of the main vehicles that delivers it where it’s needed.

How GHK-Cu Actually Works

Most peptides bind a receptor. One receptor, one pathway, one downstream effect. GHK-Cu doesn’t play that game. It acts more like a system-wide signal — touching multiple pathways at once, which is part of why its effects are so broad and, honestly, a bit unusual for something this small.

Copper Delivery

Think of GHK-Cu as a copper taxi. It grabs Cu²⁺ and drops it off wherever cells are running low. That matters because over 30 enzyme systems depend on copper — collagen cross-linking, free radical cleanup, mitochondrial energy production. Age, injury, disease — all of these reduce copper availability, and the enzymes downstream suffer for it. GHK-Cu basically keeps the supply chain from breaking.

Gene Expression — and This Is Where It Gets Wild

Researchers ran GHK through the Broad Institute’s Connectivity Map database. What they found stopped people in their tracks: 4,048 human genes affected by a single tripeptide. That’s 6% of the genome.

Six percent. From three amino acids and a copper ion.

Collagen genes, growth factor genes, integrin expression — all turned up. Inflammatory mediators, metalloproteinases running too hot, excess fibrinogen production — turned down. Researchers started describing it as a “genome reset,” because the pattern in aged cells shifted back toward what you’d expect from younger tissue (PMID: 25815981). Which, if you think about it, is exactly what Pickart saw in his liver cells back in ’73. Same observation, just now we can see the machinery behind it.

Extracellular Matrix Remodeling

Here’s something that distinguishes GHK-Cu from compounds that only build or only break down tissue: it does both, in balance. Collagen I and III production goes up. Elastin, decorin, and glycosaminoglycan synthesis increase. Simultaneously, MMP activity (the enzymes that digest matrix) gets regulated alongside their inhibitors (TIMPs). Too much building and you get fibrosis. Too much breakdown and tissue falls apart. GHK-Cu walks the line — organized remodeling instead of chaos.

Wound Healing and Skin Research

This is the most studied application, and the data is extensive.

Collagen Production

A 9-fold increase in collagen synthesis. That’s what researchers saw in rat wound models using peptide-incorporated collagen (PIC) dressings with GHK (PMC6073405). Both Type I collagen (structural support) and Type III collagen (flexibility and early-stage repair) went up. The copper component drives proper collagen architecture through lysyl oxidase and lysyl hydroxylase — the enzymes that handle cross-linking and structural stability. GHK-Cu also boosts decorin, a proteoglycan that organizes collagen fibers into ordered structures rather than scar tissue.

Wound Closure

In animal models, the healing data is consistent across multiple setups:

• Ischemic wounds (rats): GHK-Cu treated wounds healed faster, with decreased MMP-2, MMP-9, and TNF-β levels vs. controls
• Rabbit wounds: GHK alone or combined with helium-neon laser improved wound contraction, boosted granulation tissue, increased antioxidant enzyme activity, and stimulated new blood vessel growth
• Diabetic rat models: PIC dressings with GHK showed higher glutathione and ascorbic acid levels, better epithelialization, and stronger fibroblast activation

New Blood Vessel Formation

Wounds can’t heal without blood supply. GHK-Cu promotes VEGF expression and endothelial cell migration in preclinical models — two critical drivers of angiogenesis. New vessels mean oxygen and nutrients reach damaged tissue faster. It’s one of those effects that amplifies everything else GHK-Cu does for wound repair.

Anti-Inflammatory Effects

NF-κB is the master switch for inflammatory gene expression. Flip it on and you get a cascade — cytokines, chemokines, adhesion molecules, the works. GHK-Cu dials it back. That alone would be noteworthy, but the anti-inflammatory story doesn’t stop there.

In ischemic wound models, TNF-β levels dropped in GHK-Cu treated tissue compared to controls. TGF-β signaling — which is tricky because it plays roles on both the inflammatory and repair sides — gets modulated rather than simply suppressed. IL-6 expression shifts too, nudging the wound environment away from active inflammation and toward the repair phase (PMC6073405). Not just dampening the fire. Redirecting the tissue toward rebuilding.

Other Research Areas Worth Knowing About

Antioxidant Activity

SOD activity up. Glutathione levels up. Ascorbic acid concentrations in wounded tissue — also up. GHK-Cu consistently boosts the cellular antioxidant defense system in preclinical models. If you’re researching oxidative stress in the context of tissue injury, this peptide keeps showing up in the data for good reason.

Lung Tissue

This one caught several research groups off guard. Fibroblasts from COPD patients exposed to GHK-Cu started expressing genes in patterns that looked more like healthy lung cells. It’s early-stage work and nobody’s making clinical claims yet, but the lung regeneration angle has attracted enough interest that multiple labs are now chasing it.

Nervous System

Still early days here. Animal models show anti-anxiety-like and pain-reducing effects, probably running through GHK-Cu’s broad gene modulation and inflammation pathways rather than any direct hit on neuroreceptors. The nervous system data is thin compared to the wound healing research, but it keeps this peptide on the radar for neuroscience-adjacent work.

GHK-Cu in Multi-Peptide Blends

One peptide doing a lot? Good. Multiple peptides hitting different mechanisms at the same time? That’s where multi-compound blends come in. Loti Labs offers two that build on GHK-Cu’s foundation.

Glow Blend

The Glow Blend (70mg) stacks three peptides with different jobs:

Component	Amount	What It Brings to the Table
GHK-Cu	50mg	Collagen synthesis, gene modulation, antioxidant activity
BPC-157	10mg	Angiogenesis, gut-organ axis signaling, tissue repair
TB-500	10mg	Actin regulation, cell migration, tissue remodeling

Why these three? They don’t overlap much. GHK-Cu handles collagen and broad gene modulation. BPC-157 drives blood vessel formation and growth factor signaling — different axis entirely. TB-500 works the structural side through actin regulation and cell migration. Three entry points into tissue repair instead of one.

Klow Blend

The Klow Blend (80mg) takes the Glow formula and adds a fourth component:

Component	Amount	What It Brings to the Table
GHK-Cu	50mg	Collagen synthesis, gene modulation, antioxidant activity
BPC-157	10mg	Angiogenesis, gut-organ axis signaling, tissue repair
TB-500	10mg	Actin regulation, cell migration, tissue remodeling
KPV	10mg	Melanocortin receptor activation for anti-inflammatory effects

Why add KPV? It hits melanocortin receptors — a totally separate anti-inflammatory pathway from GHK-Cu’s NF-κB work or BPC-157’s growth factor modulation. If your protocol has an inflammation component, that extra axis of coverage can make the difference between adequate and thorough inflammatory control.

Glow vs. Klow — Which One?

The honest answer: it depends on how much anti-inflammatory coverage your protocol needs. Glow gives you the regenerative trifecta — collagen, angiogenesis, and cell migration — at $149.99 for 70mg total. Klow adds KPV’s melanocortin-based anti-inflammatory pathway on top of that for $199.99 (80mg total).

If inflammation is central to what you’re studying, the Klow upgrade is probably worth it. Three separate anti-inflammatory mechanisms (NF-κB via GHK-Cu, growth factor modulation via BPC-157, melanocortin receptors via KPV) beats two. If you’re more focused on tissue remodeling and repair, Glow covers the essentials without the extra cost.

Safety — What Researchers Should Watch For

It’s naturally present in human blood, so the toxicity profile starts in a pretty good place. Preclinical data confirms that. But “low toxicity” doesn’t mean “zero things to think about.”

First, carboxypeptidases will tear this peptide apart — fast. Wound serum is especially aggressive. If your experimental design doesn’t account for enzymatic degradation, your results will be all over the place. Second, dose matters more than most people realize. The effects are concentration-dependent in ways that aren’t always linear, so skipping dose-response curves in your model is asking for trouble.

Third — and people forget this one — copper adds up. Yes, it’s an essential trace element. Yes, you need it. But if you’re running multiple copper-containing compounds or high-dose protocols, total Cu²⁺ exposure needs to be tracked. Too much copper creates its own set of problems.

Storage? Nothing complicated. Reconstituted solutions go to 2–8°C, keep them out of light. The lyophilized powder is stable under normal storage conditions.

One more thing: GHK-Cu is an investigational research compound. Not FDA-approved. Laboratory research use only.

Product Specs

Available as standalone peptide, capsules, or in pre-formulated blends — depends on what your protocol calls for:

Product	Format	Amount	Price
GHK-Cu 50mg	Lyophilized powder	50mg	$49.99
GHK-Cu Capsules	Capsules (2mg/capsule, 30 count)	60mg total	$59.99
Glow Blend 70mg	Multi-peptide blend	70mg (GHK-Cu 50mg + BPC-157 10mg + TB-500 10mg)	$149.99
Klow Blend 80mg	Multi-peptide blend	80mg (GHK-Cu 50mg + BPC-157 10mg + TB-500 10mg + KPV 10mg)	$199.99

All Loti Labs compounds go through third-party purity and identity testing. Wondering how to vet peptide suppliers in general? We put together a supplier evaluation guide that covers what actually matters.

So Where Does GHK-Cu Stand?

Fifty years in, and researchers are still pulling new findings out of a compound made from three amino acids and a copper ion. Pickart couldn’t have predicted the gene expression data when he was watching liver cells in 1973. Nobody could have. A tripeptide affecting 6% of the human genome? That’s not the kind of thing you put in your grant proposal and expect to be taken seriously. But here we are.

The collagen work is solid, well-replicated across models. The inflammatory data is consistent. And that Connectivity Map gene profiling is, frankly, hard to ignore for anyone working in regenerative or age-related research. Standalone GHK-Cu works for focused studies. The Glow and Klow blends stack complementary mechanisms. Either way — there’s a reason this peptide keeps showing up in the literature after half a century.

Curious about the other peptides we covered? Here’s our deep dive on BPC-157, our breakdown of TB-500, and a look at KPV research.

References

1. Pickart L. The human tri-peptide GHK and tissue remodeling. J Biomater Sci Polym Ed. 2008;19(8):969-988. doi:10.1163/156856208784909435
2. Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Biomed Res Int. 2015;2015:648108. PMID: 26236730; PMC4508379
3. Pickart L, Vasquez-Soltero JM, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci. 2018;19(7):1987. PMID: 29986520; PMC6073405
4. Pickart L, Vasquez-Soltero JM, Margolina A. GHK-Cu may prevent oxidative stress in skin by regulating copper and modifying expression of numerous antioxidant genes. Cosmetics. 2015;2(3):236-247.
5. Maquart FX, Pickart L, Laurent M, et al. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Lett. 1988;238(2):343-346. PMID: 3169264
6. Siméon A, Wegrowski Y, Bontemps Y, Maquart FX. Expression of glycosaminoglycans and small proteoglycans in wounds: modulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu(2+). J Invest Dermatol. 2000;115(6):962-968. PMID: 11121126
7. Lamb JR, Crawford ED, Peck D, et al. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science. 2006;313(5795):1929-1935. PMID: 17008526
8. Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide. Int J Mol Sci. 2018;19(7):1987. PMID: 25815981

Disclaimer: This article is for informational and educational purposes only. GHK-Cu is sold as a research compound for laboratory investigation. It is not intended for human consumption and has not been approved by the FDA for any medical use. All research cited refers to preclinical and in vitro studies. Loti Labs does not make any claims regarding the use of this compound outside of a controlled research setting.